Mind Medicine Inc (NASDAQ:MNMD) shares, rose in value on Thursday, March 27, with the stock price down by -2.28% to the previous day’s close as strong demand from buyers drove the stock to $6.43.
Actively observing the price movement in the last trading, the stock closed the session at $6.58, falling within a range of $6.28 and $6.5707. The value of beta (5-year monthly) was 2.398. Referring to stock’s 52-week performance, its high was $12.22, and the low was $5.03. On the whole, MNMD has fluctuated by -5.72% over the past month.
With the market capitalization of Mind Medicine Inc currently standing at about $484.62 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Mar-05.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that MNMD’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of Hold while long-term indicators on average have been pointing out that it is a 50% Sell.
The stock’s technical analysis shows that the price of MNMD currently trading nearly -1.29% and -10.76% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 43.18, while the 7-day volatility ratio is showing 5.37% which for the 30-day chart, stands at 6.77%. Furthermore, Mind Medicine Inc (MNMD)’s beta value is 2.37, and its average true range (ATR) is 0.49.
A comparison of Mind Medicine Inc (MNMD) with its peers suggests the former has fared considerably weaker in the market. MNMD showed an intraday change of -2.28% in last session, and over the past year, it shrunk by -38.35%%.
Data on historical trading for Mind Medicine Inc (NASDAQ:MNMD) indicates that the trading volumes over the past 10 days have averaged 1.07 and over the past 3 months, they’ve averaged 2.00 million. According to company’s latest data on outstanding shares, there are 75.37 million shares outstanding.
Nearly 1.20% of Mind Medicine Inc’s shares belong to company insiders and institutional investors own 49.60% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 11.37 million shares as on 2025-03-14, resulting in a short ratio of 4.92. According to the data, the short interest in Mind Medicine Inc (MNMD) stood at 1510.00 of shares outstanding as of 2025-03-14; the number of short shares registered in 2025-02-14 reached 10.89 million. The stock has fallen by -7.61% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the MNMD stock heading into the next quarter.
